Loading...
The crosstalk between prostate cancer and microbiota inflammation: Nutraceutical products are useful to balance this interplay?
Crocetto, F Boccellino, M Barone, B Di Zazzo, E Sciarra, A Galasso, G Settembre, G Quagliuolo, L Imbimbo, C Boffo, S
Crocetto, F
Boccellino, M
Barone, B
Di Zazzo, E
Sciarra, A
Galasso, G
Settembre, G
Quagliuolo, L
Imbimbo, C
Boffo, S
Citations
Altmetric:
Genre
Review
Journal
Journal
Date
2020-09-01
Advisor
Committee member
Group
Department
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
10.3390/nu12092648
Abstract
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. The human microbiota shows pivotal roles in urologic health and disease. Emerging studies indicate that gut and urinary microbiomes can impact several urological diseases, both benignant and malignant, acting particularly on prostate inflammation and prostate cancer. Indeed, the microbiota exerts its influence on prostate cancer initiation and/or progression mechanisms through the regulation of chronic inflammation, apoptotic processes, cytokines, and hormonal production in response to different pathogenic noxae. Additionally, therapies’ and drugs’ responses are influenced in their efficacy and tolerability by microbiota composition. Due to this complex potential interconnection between prostate cancer and microbiota, exploration and understanding of the involved relationships is pivotal to evaluate a potential therapeutic application in clinical practice. Several natural compounds, moreover, seem to have relevant effects, directly or mediated by microbiota, on urologic health, posing the human microbiota at the crossroad between prostatic inflammation and prostate cancer development. Here, we aim to analyze the most recent evidence regarding the possible crosstalk between prostate, microbiome, and inflammation.
Description
Citation
Citation to related work
MDPI AG
Has part
Nutrients
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu